An infusible drug designed to treat patients who have been exposed to anthrax has been approved by the U.S. Food and Drug Administration (FDA), health officials announced Wednesday. The drug, Anthrasil, is made of antibodies from individuals who have been vaccinated against anthrax.
Anthrax is a serious infectious disease that, while rare, can spread through infected animals or contaminated animal products. However, in the case of a bioterrorism attack, Bacillus anthracis, the bacteria that causes anthrax, can be used in powders, sprays, food and water to spread the microscopic...
Also read: Choosing low-carb foods can help your health